Novartis ag NVS.US 總覽分析
)NVS 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分優異，股利評分名列前茅，值得長期累積部位。若想獲得較好的進場時機，可參考技術面趨勢與波段評分
NVS 近期報酬表現
2.66%
Novartis ag
3.56%
同產業平均
1.47%
S&P500
與 NVS 同產業的標的表現
- AZN Astrazeneca plc價值 4 分趨勢 3 分波段 5 分籌碼 2 分股利 5 分查看更多
NVS 公司資訊
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.